Supernus Pharma (SUPN) Proposed Private Offering of $350 Million of Convertible Senior Notes
Tweet Send to a Friend
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) (the “Company”), a specialty pharmaceutical company focused on developing and commercializing products for the treatment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE